Key Staff

• 

  Colin Swinburne

  Chemistry Team Leader - Intermediates

  Colin Swinburne joined Key Organics in 1999 after working for Invensys.
  
  He had previously completed his degree at Leicester University (1996) which included a year of industrial placement at Astra, Loughborough.
  
  Colin has worked for BIONET Intermediates since 2001 and he currently holds the position of Team Leader.
  
  He is responsible for ensuring that the BIONET Intermediates catalogue continues to offer new, novel, quality compounds that are appealing to the discerning synthetic chemist.
  

• 

  Matthew Stent

  Chemistry Team Leader – Custom Synthesis & FTE/Contract

  Matthew Stent joined Key Organics in 2005 as a synthetic chemist and worked across all product sectors, including production of catalogue compounds, time-critical & complex custom synthesis and FTE (contract) chemistry.
  
  Matthew has held the position of Chemistry Team Leader since mid-2008; he was responsible for the New Product Development section for two years, overseeing development of new product lines and expansion of our catalogue through collaborations and procurement and is now charged with managing all aspects of KOCAS Custom Synthesis and FTEs, including communication, operations and support.
  
  Matthew is a graduate of the University of Bristol (1999), obtained his D.Phil. from the University of Oxford (2002), where he worked under the supervision of Prof. David Hodgson on the development and application of new synthetic methodology, especially asymmetric desymmetrisation of epoxides, and spent two years (2003-4) in Prof. Phil Magnus's group in Austin, Texas, carrying out post-doctoral research towards the total synthesis of the rocaglamides.

• 

  Andrew Lowerson

  Chemistry Team Leader

  Andrew Lowerson joined Key Organics in the spring of 1998. He had previously spent time in the Armed Forces (Army) and worked as an Administration Officer in Local Government.
  
  Since joining Key Organics Andrew has worked on the synthesis of Screening compounds, Intermediates, and Assay Standards. He has also worked in the area of Custom Synthesis and as an FTE Project Leader.
  
  Andrew completed a Degree in Chemistry with Medicinal Chemistry at The University of Hertfordshire (1997).
  
  He is the Chemistry Team Leader responsible for developing new product lines and expansion of the Bionet Catalogue through collaborations and procurement.